From owner-diagnostics@net.bio.net Mon Apr 05 23:00:00 1999 Path: biosci!biosci!not-for-mail From: BIOSCI Administrator Newsgroups: bionet.diagnostics Subject: BIOSCI/bionet miniFAQ & Fundraiser Date: 6 Apr 1999 01:49:23 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 233 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7echqj$oi5@net.bio.net> NNTP-Posting-Host: net.bio.net (LAST REVISION: 30-JUL-95) This BIOSCI "miniFAQ" is designed to answer the questions that come up the *most frequently*. The main BIOSCI FAQ (Frequently Asked Questions) is accessible on the World Wide Web at URL http://www.bio.net/. If you can not find an answer to your question in this or other documentation, the BIOSCI technical support staff answers e-mail queries sent to biosci-help@net.bio.net We can only answer questions about the use of the newsgroups and mailing lists. We unfortunately do not have the staff to do Internet information searches or answer scientific questions. Please post those to the appropriate BIOSCI/bionet newsgroups. Contents: -------- 0) BIOSCI NEEDS YOUR SUPPORT!! 1) Using the WWW to access the BIOSCI/bionet newsgroups. 2) What to do about "spams," i.e., junk mail, ads, etc. 3) Examples of subscribing and unsubscribing to the mailing lists. 4) The BIOSCI user address and research interest directory. 0) BIOSCI NEEDS YOUR SUPPORT!! ------------------------------ BIOSCI's government funding has been expended, and we are now operating solely from advertising revenue that we have raised from our Web site at http://www.bio.net/. We need just a few minutes of your time to help us serve you. You can do two important things which will take very little time for you individually and will immensely help us continue to help you. First, please use our WWW system at http://www.bio.net/ to access the archives. You can post or reply to messages via your Web browser as described in item #1 below. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. 1) Using the WWW to access the BIOSCI/bionet newsgroups. -------------------------------------------------------- As of 10 December 1995, all BIOSCI/bionet full newsgroups are accessible through the World Wide Web (WWW) at URL http://www.bio.net. One can read and reply publicly or privately to both recent postings and archived messages through one's Web browser if it is configured properly to send e-mail. Each newsgroup is equipped with its own WAIS index. The main BIOSCI home page also has access to the BIO-JOURNALS Table of Contents database WAIS index and the BIOSCI user address database described in another item further below. 2) What to do about "spams," i.e., junk mail, ads, etc. ------------------------------------------------------- BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups), mailing lists, and a hypermail archive at URL http://www.bio.net/. The same postings are distributed on all media (except for a small number of mailing-list-only groups at net.bio.net). Unfortunately it is becoming a despicable practice on the Internet (by a few people out to make a fast buck) to do automated mass postings to thousands of newsgroups and mailing lists. These attempts to grab free advertising are refered to as "spams" in the usual, somewhat boneheaded, net terminology. USENET is more susceptible to this practice, and many spams originate on the USENET groups and then are passed on to the mailing lists. However, spammers also get lists of mailing addresses and hit these too, so neither medium is immune. What should you do personally if you get junk mail? --------------------------------------------------- Just delete it and move on without reading it further. Filing a protest is becoming increasingly useless because spammers are often disguising the addresses where the messages are sent from. Unless you really understand Internet mail systems, your attempt at protest by sending replies to the message will often end up being sent to the address of an innocent person that the spammer is victimizing. What can BIOSCI/bionet do to protect its newsgroups? ---------------------------------------------------- The only solution currently available is to moderate the newsgroup. If this newsgroup is already moderated, then you are in good shape. Moderation protects the USENET distribution from about 95% of the spams that are being sent to date and protects the mailing lists completely. Moderation means, however, that someone has to take the time to review each message before it goes out. We have set up software here that simply allows the moderator to forward to an address at net.bio.net messages that (s)he wishes to have distributed. This takes no more time than that needed to read the message and pass it on, say about 1 min. per message. Most newsgroups currently have a discussion leader who is responsible for their newsgroup. The discussions leaders and their e-mail addresses are listed in the BIOSCI Information Sheet which is available on the Web at http://www.bio.net/. If a newsgroup is being hit with too many junk postings, please contact the discussion leader for that group and see if there is interest in moderating the group. Please do not assume that by simply posting a complaint to the newsgroup itself, anyone on the BIOSCI staff will act on your complaint. With close to 100 newsgroups to run, the BIOSCI staff has to rely on the discussion leaders of each newsgroup to report problems directly to us at biosci-help@net.bio.net. We will moderate any of our newsgroups if the discussion leader tells us that the readership of the group wishes to do so and if a moderator is willing to do the work. For most BIOSCI/bionet groups, this entails only a few minutes of work each day. Moderating a newsgroup will resolve probably 95% of the junk postings on the USENET distribution. Unfortunately there are easy ways for determined spammers to override the moderation mechanism on USENET, but we can protect our e-mail subscribers from unwanted postings if the newsgroup is moderated. You can also access our newsgroups over the WWW at URL http://www.bio.net. While this Web interface will not stop spammers from trying to post to the groups, this will give you yet another way, besides using USENET news, to keep the junk out of your personal mail files. For those of you with local USENET news systems, the Web interface will also give you faster access to new newsgroups and recent postings. 3) Examples of subscribing and unsubscribing to the mailing lists. ------------------------------------------------------------------ PLEASE NOTE: The BIOSCI management does NOT act on subscription/unsubscription requests that are posted improperly to the newsgroups and mailing lists. People who do this only bother everyone on the lists to no avail. Please be sure to follow the proper procedures below. Gory details are in the BIOSCI Information sheets on the Web at http://www.bio.net. Below we give an example utilizing the METHODS-AND-REAGENTS list at both of our two BIOSCI sites: Users in the Americas and Pacific Rim countries who use the BIOSCI ------------------------------------------------------------------ node at computer net.bio.net: ---------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@net.bio.net. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to biosci-server@net.bio.net. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Do NOT put your e-mail address or other text on these lines. The server only allows you to cancel your subscription if the address on your mail header matches the address on our mailing list. Please ask for help at biosci-help@net.bio.net if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. Users in Europe, Africa, and Central Asia who use the BIOSCI node at -------------------------------------------------------------------- computer daresbury.ac.uk (also known as dl.ac.uk): ------------------------------------------------- To subscribe and unsubscribe to/from the BIOSCI lists, you need to specify the full USENET newsgroup name with "bionet-news." prepended. The USENET newsgroup names are listed in the BIOSCI Information sheet on the Web at http://www.bio.net/. For the METHODS-AND-REAGENTS list the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the appropriate commands are sub bionet-news.bionet.molbio.methds-reagnts unsub bionet-news.bionet.molbio.methds-reagnts These commands are included in a message addressed to mxt@dl.ac.uk, NOT to the newsgroup mailing addresses. As usual, include the text in the body of the message as text on the Subject: line is ignored. To unsubscribe from all the lists at the UK node, use unsub bionet-news Please note that if the address in the list is different than the one in your mail message header, you will not be able to unsubscribe by this method. If you have problems, please mail biosci@daresbury.ac.uk. 4) The BIOSCI user address and research interest directory. ----------------------------------------------------------- Please take this opportunity to add your name, address, and research interest information to the BIOSCI User Address Database if you have not already done so. You can fill out the address form directly through our Web page at URL http://www.bio.net/adrform.html. The address database is reindexed nightly for WWW access (the URL is http://www.bio.net/). If you are not directly on the Internet but can reach it by e-mail, please use our waismail server to access the user directory. waismail use is described above. You can also request a user address form by e-mail from biosci-help@net.bio.net. Please check your database entry from time-to-time to see if your address information is still up-to-date. Because of our limited personnel resources, we ask that you resubmit a *complete* form to revise your entry; we only replace complete entries and do not have resources to edit old forms. From owner-diagnostics@net.bio.net Mon Apr 05 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Leigh Bangs Newsgroups: bionet.diagnostics Subject: Diagnostic Applications of Latex Technology: May 19-21; Indianap Date: 6 Apr 1999 01:49:23 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 24 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7echqj$oi2@net.bio.net> NNTP-Posting-Host: net.bio.net The twelfth running of The Latex Course or "Diagnostic Applications of Latex Technology: Theory and Practice" will be May 19-21 in Indianapolis, Indiana, USA. This is a proven, in-depth, practical short course presenting the latest development methods and new alplications for microparticle or microsphere (latex)-based diagnostic tests and assays. Immunoassays and tests are discussed in detail as well as newer applications of the technology in molecular biology.The course is sponsored by Bangs Laboratories and Emerald Diagnostics, featuring a truly international faculty of 11 respected speakers in this area. Details and course brochure can be found at the website http://www.bangslabs.com/ For a brochure by mail, send a message with your address to info@bangslabs.com ; call 800-387-0672 or 317-570-7020; or fax to 317-570-7034. oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo Leigh Bangs, aka "The Particle Doctorr"; leigh@bangslabs.com Bangs Laboratories, Inc., 9025 Technology Drive, Fishers, IN 46038-2886 USA Tel: 800-387-0672 or 317-570-7020 Fax: 317-570-7034 "The Microsphere Zone" [Web Site: http://www.bangslabs.com] oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo From owner-diagnostics@net.bio.net Mon Apr 05 23:00:00 1999 Path: biosci!biosci!not-for-mail From: immunechem Newsgroups: bionet.diagnostics Subject: anti-glycated glucose Date: 6 Apr 1999 01:57:20 -0700 Organization: Internet Gateway Lines: 5 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7eci9g$p0a@net.bio.net> NNTP-Posting-Host: net.bio.net We recently produced specific antibodies against glycated glucose (not the ring structured glucose but linked to BSA through Schiff-base. The antibody is purified by glycated w-aminocaproic acid agarose. Is it possible to use it for diagnosis of diabetus. Any comment? From owner-diagnostics@net.bio.net Mon Apr 05 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Kevin O'Donnell Newsgroups: bionet.diagnostics Subject: Virology News Daily - from Retroscreen and All the Virology on t Date: 6 Apr 1999 09:00:09 -0700 Organization: Scottish Agricultural Science Agency Lines: 85 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7edb29$7os@net.bio.net> NNTP-Posting-Host: net.bio.net Daily Virology News -- For Free Retroscreen Virology and All the Virology on the WWW are launching a new FREE OF CHARGE service for those interested in virology. We have arranged for a virology-related email newsfeed from over 300 international news sources including the New York Times and BBC online. If you would like to receive these email updates please register at the Retroscreen Website: http://www.retroscreen.com/daily_virology_news.htm or at All the Virology on the WWW: http://www.tulane.edu/~dmsander/dvnreg.html Thanks for your support! The Daily Virology News is brought to you by Retroscreen http://www.retroscreen.com and All the Virology on the WWW http://www.tulane.edu/~dmsander/garryfavweb.html If you would like to contribute to our news keywords survey please go to http://www.retroscreen.com/daily_virology_news_keyword_surv.htm. ---------------------------------------------------------------------------- About All the Virology on the WWW: http://www.tulane.edu/~dmsander/garryfavweb.html This comprehensive page lists all the WWW sites that contain information about Virology, Epidemiology and Public Health, General Virology, Specific Viruses, Microbiology, AIDS, Emerging Viruses, Vaccines, Gene Therapy, Biological Warfare, Taxonomy, Virology and Microbiology News, Academic Departments, Virology Institutes, Genomic data, research labs and other Health Related Sites in addition to web sites regarding Science Jobs, Scientific Meetings, Government Agencies, Journals, Scientific Societies, Patent and Legal Resources, Scientific Companies, and much, much more. All the Virology on the WWW also contains On-line Virology Course Notes, a Virology Bookshop, and a catalog of viral images - The Big Picture Book of Viruses. This site is maintained and updated often. Any submissions, additions or corrections that you might have would be very much appreciated, and can be made using the following form: http://www.tulane.edu/~dmsander/garryfavwebadd.html With your assistance, this Web Site will continue to be the best resource of its kind on the web. For those of you who maintain your own web pages, please send me your address or use our site submission form and I will gladly add it to the list. ---------------------------------------------------------------------------- (Please note that netiquette forbids us from sending out information releases to those individuals who do not wish to receive them. Our distribution list is small, and hand selected. All recipients of our releases were added to this seldom used (last message in July 1998) list after a visit to our Internet site or from a request to be included. On rare occasions we make a mistake and inadvertently send out material which you may not wish to receive. Please send us a nice note and we will remove you from our list immediately). _/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/ David M. Sander, Ph.D E-Mail: dmsander@ix.netcom.com Sander & Associates, Consultants 2561 East Tiffany Lane Fax: (916) 361-7281 Sacramento, CA 95827-1403 Phone: (916) 362-8433 (home) All the Virology: http://www.tulane.edu/~dmsander/garryfavweb.html Personal WWW Homepage: http://www.tulane.edu/~dmsander/DMS/DMSHomePage.html _/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/_/ From owner-diagnostics@net.bio.net Mon Apr 05 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Paula Newsgroups: bionet.diagnostics Subject: Anti-CMV antibodies Date: 6 Apr 1999 07:08:33 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 12 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ed4h1$ovt@net.bio.net> NNTP-Posting-Host: net.bio.net We are looking for an anti-CMV pp65 monoclonal antibody to use in flow cytometry. Does anybody have any experience with this? Paula Lavery Transplant Immunology Laboratory Royal Victoria Hospital McGill University plaver@po-box.mcgill.ca From owner-diagnostics@net.bio.net Tue Apr 06 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Kevin O'Donnell Newsgroups: bionet.diagnostics Subject: HIV Meeting Date: 7 Apr 1999 01:29:38 -0700 Organization: Scottish Agricultural Science Agency Lines: 29 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ef51i$3r1@net.bio.net> NNTP-Posting-Host: net.bio.net Subject: HIV Meeting Targeting HIV Reservoirs and Reconstituting the Immune System April 18-19, 1999 The French Embassy 4101 Reservoir Road NW, Washington, DC Keynote Speaker A. Fauci, NIH Sessions • Viral Reservoirs • Targeting Cellular Factors • Antiviral Therapy • Cellular Immune Response and Reconstitution • Genetic Approaches • Immunotherapy • Dendritic Cells • New Insights into HIV Pathogenesis and Therapy Contact: Susanne Varga-Braun 202-687-9197 svargabraun@hotmail.com\ From owner-diagnostics@net.bio.net Tue Apr 06 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Sandra Hutt Newsgroups: bionet.diagnostics Subject: CSPS Symposium and Call For Abstracts/Posters Date: 7 Apr 1999 08:30:27 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 88 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7eftmj$qla@net.bio.net> NNTP-Posting-Host: net.bio.net > 2nd Annual Symposium of the Canadian Society for Pharmaceutical > Sciences (CSPS) > > Friday, August 27th, 1999 & Saturday, August 28th, 1999 > > Le Centre Sheraton Hotel, Montreal, Quebec, Canada > > "Exploring Human Diversity in Drug Development and Pharmacotherapy" > > Programme Topics > > Pharmaceutical Research and Drug Development in the New > Millennium. > > New Advances in Human Diversity. > This section will highlight important new advances in our > understanding of individual factors involved in pharmacokinetic and > pharmacodynamic variability. Speakers will focus on the contributing > role of age, gender, disease and genetic polymorphism in intersubject > variability. > > The New Era of Pharmacogenomics > This section will concentrate on methods involved in > pharmacogenetic studies as well as the clinical application of > pharmacogenetic research. Speaker topics will introduce the audience > to pharmacogenetics, pharmacogenomics, proteomics and bioinformation > sources in drug development, subject selection and clinical study > design. > > Subject Selection in Drug Testing. > This section will provide an in depth discussion on subject > selection in clinical trials with a focus on regulatory aspects. > Issues pertaining to inter- and intra- subject variability in > bioequivalency studies and current views on the inclusion of women and > other targeted patient groups in clinical trials will be presented. > The audience will have the opportunity to critically discuss current > regulatory perspectives on these issues. > > Challenges of Drug Delivery to Targeted Patients. > This section will summarize issues encountered in drug delivery > to special population groups with emphasis on pediatric, geriatric and > palliative care patients. Speakers will provide examples and address > special concerns of drug delivery to these patients. This symposium > will also include a discussion on novel advances in the use of gene > therapy to treat diseases such as cystic fibrosis. > > Programme, registration, and abstract/poster information is > posted on the website. > http://www.ualberta.ca/~csps > > ______________________________________________________________________ > _____________________ > CSPS Call for Abstracts/Posters > > "Exploring Human Diversity In Drug Development and Pharmacotherapy" > > Abstracts and posters are being accepted for the 2nd Symposium of the > Canadian Society for Pharmaceutical Sciences in Montreal, Quebec, > Canada. The deadline for submission is June 25th, 1999, and authors > will be informed of acceptance by July 5th, 1999. Posters presented > elsewhere within the last 12 months are acceptable. Abstracts may be > submitted in either English or French and must contain an adequate > body of data with the Purpose, Methods, Results and Conclusion > headings. The length of the poster must be between 250 to 500 words > with the title in capital letters and the name of the presenter > underlined. Abstracts may be submitted electronically online, or by > email. > > Work that has been presented elsewhere must be clearly acknowledged > with the name of the meeting, the date of the original presentation, > and referenced to the publication if abstract has been published. > Posters will be displayed on both days of the conference, and authors > must be present to discuss their work during all four break periods. > To present a paper or poster, please indicate so on the Notice of > Intention Page. > http://www.pharmacy.ualberta.ca/CSPSConferenceSite/intention.htm > > Sandra Hutt, Administrator > Canadian Society for Pharmaceutical Sciences > "Journal of Pharmacy & Pharmaceutical Sciences" > 3118 Dentistry/Pharmacy Centre > University of Alberta Campus > Edmonton, Alberta, Canada, T6G 2N8 > Tel: (780) 492-0950 > Fax: (780) 492-0951 > http://www.ualberta.ca/~csps > mailto:Sandra.Hutt@ualberta.ca > From owner-diagnostics@net.bio.net Wed Apr 07 23:00:00 1999 Path: biosci!biosci!not-for-mail From: immunechem Newsgroups: bionet.diagnostics Subject: glycated glucose Date: 8 Apr 1999 01:22:27 -0700 Organization: Internet Gateway Lines: 9 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ehp03$77@net.bio.net> NNTP-Posting-Host: net.bio.net We have developed certain antibodies against glucose linked to proteins. They are purified on glycated polylysine affinity column. Could they be utilized for diagnosis of glucose control in diabetic patient? Beside, these Ab appear have broad specificity to glycated BSA, hemoglobin regardless of species (rabbit, bovine and chicken). Any comment? From owner-diagnostics@net.bio.net Wed Apr 07 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Paula Newsgroups: bionet.diagnostics Subject: Permeabilization of cells by paraformaldehyde-methanol for FCM Date: 8 Apr 1999 01:22:56 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 17 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ehp10$7u@net.bio.net> NNTP-Posting-Host: net.bio.net I am looking for a reference in Cytometry and cannot find the journal anywhere here at McGill. Apparently it will take the library several weeks to obtain it. Can anyone help out? The reference is: Schimenti, K., and J. Jaccobberger. 1992. Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence. Cytometry 13:48-59. Thanks for your help! Paula Lavery Transplant Immunology Laboratory Royal Victoria Hospital McGill University From owner-diagnostics@net.bio.net Wed Apr 07 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Bodenteich Newsgroups: bionet.diagnostics Subject: immunoassay for GAD Date: 8 Apr 1999 01:24:26 -0700 Organization: Customer of EUnet Austria Lines: 8 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ehp3q$b9@net.bio.net> NNTP-Posting-Host: net.bio.net Hi, There exists an immunoassay for GAD. I was told that this assay is sold by a company named "Brahms Immunodiagnostics" in Hamburg. I am not sure about the correct spelling of the company name, so far I could not find the company. Does anybody know this company? Thanks for your help Angelika bodenteich@EUnet.at From owner-diagnostics@net.bio.net Sun Apr 11 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Victor Fursov Newsgroups: bionet.diagnostics Subject: ask for literature / Ukraine Date: 12 Apr 1999 01:39:23 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 28 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7esbfr$pkv@net.bio.net> NNTP-Posting-Host: net.bio.net Dear Colleagues, Could you help me in new references/ copies of your publications about: Marker chromosome, derived from chromosome 22, or Cat Eye syndrome and marker chromosome 22, or deletion chromosome 9(q21-qter). Your kind help will be very much appreciated. Our current literetaure access is very limited. Sincerely, Dr.Zerova Tatiana Department of Medical Genetics, Kiev Medical Academy of Post-Graduate Education, Ministry of Health of Ukraine, Kiev, Vladimirskaya Street, D-51/53, KB-73, UKRAINE. TEL: (44)-224-9980. TEL: (44)-224-9333. fax: (44)-229-6940. e-mail: fursov@ukrpack.net ---- Victor Fursov fursov@meijo-u.ac.jp From owner-diagnostics@net.bio.net Sun Apr 11 23:00:00 1999 Path: biosci!biosci!not-for-mail From: KOCH Newsgroups: bionet.diagnostics Subject: Kindliches Fieber - Child's Fever Date: 12 Apr 1999 01:40:52 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 13 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7esbik$poo@net.bio.net> NNTP-Posting-Host: net.bio.net Unsere Tochter, 4 Jahre, hat ca. 2- 3 mal pro Jahr anhaltend hohes Fieber <42 oC Blutwerte: Leucozyten >20000 - CRP > 410 mg/l - Thrombocyten 697 Ausgeschlossen wurde: Meningitis, Leukämie, Kissing Desease, Angina, Rheuma. Herz, Nieren, Magen, Blase, Mandeln unauffällig, Therapie bisher: Fiebermittel, Antibiotika. Nach ca. 3-4 Tagen Besserung. Haben Sie einen Diagnose/Therapie - Vorschlag . Vielen Dank! rpk.koch@t-online.de From owner-diagnostics@net.bio.net Sun Apr 11 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Bernd Sebastian Kamps Newsgroups: bionet.diagnostics Subject: AMEDEO Date: 12 Apr 1999 01:40:23 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 36 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7esbhn$pmg@net.bio.net> NNTP-Posting-Host: net.bio.net Dear Friend, AMEDEO Sexually Transmitted Diseases has been activated today. http://www.amedeo.com/medicine/std.htm The new service - like the other 45 services launched since May 1998 - includes the following: 1. weekly overviews of the new publications 2. the weekly e-mail service with a detailed bibliography and links to abstracts according to the journal subset you previously defined 3. a weekly personal webpage displaying the abstracts of your journal subset articles 4. monthly overview of last year literature grouped by journals and topics 5. the AMEDEO Network Center which will enable you to accelerate the literature exchange with the other members of your working group (collegues, collaborators, students etc.) by the Network's E-mail exchange service. Sincerely Bernd Sebastian Kamps, MD & The AMEDEO Team E-mail: Bernd.Sebastian.Kamps@AMEDEO.COM From owner-diagnostics@net.bio.net Sun Apr 11 23:00:00 1999 Path: biosci!biosci!not-for-mail From: Paul Smallwood Newsgroups: bionet.diagnostics Subject: Re: glycated glucose Date: 12 Apr 1999 01:42:53 -0700 Organization: Pulitzer Technologies, INC. Lines: 15 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7esbmd$q12@net.bio.net> NNTP-Posting-Host: net.bio.net Please contact me about this query paul@lincoresearch.com immunechem wrote in message <7ehp03$77@net.bio.net>... >We have developed certain antibodies against glucose linked to proteins. >They are purified on glycated polylysine affinity column. Could they be >utilized for diagnosis of glucose control in diabetic patient? > >Beside, these Ab appear have broad specificity to glycated BSA, >hemoglobin regardless of species (rabbit, bovine and chicken). > >Any comment? > From owner-diagnostics@net.bio.net Sun Apr 11 23:00:00 1999 Path: biosci!biosci!not-for-mail From: martin_tridelta@my-dejanews.com Newsgroups: bionet.diagnostics Subject: Acute Phase Proteins + Veterinary Laboratory Diagnostics Web Site Date: 12 Apr 1999 05:55:08 -0700 Organization: Deja News - The Leader in Internet Discussion Lines: 10 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7esqfc$i1l@net.bio.net> NNTP-Posting-Host: net.bio.net Hello All, New veterinary and animal laboratory diagnostics web site with information on a wide range of laboratory diagnostic test kits for many animal species, including Acute Phase Proteins, Virus Detection, Dermatophyte Identification and Detection and a new, colorometric, non-species specific Haptoglobin test for use as a manual or automated assay. Further information and details can be found at: www.trideltaltd.com. Hope you find it useful! Kind Regards, martin_tridelta, Dublin, Ireland -----------== Posted via Deja News, The Discussion Network ==---------- http://www.dejanews.com/ Search, Read, Discuss, or Start Your Own From owner-diagnostics@net.bio.net Mon Apr 12 23:00:00 1999 Path: biosci!biosci!not-for-mail From: KOCH Newsgroups: bionet.diagnostics Subject: Kindes Fieber - Childs Fever Date: 13 Apr 1999 01:47:18 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 17 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7ev0am$379@net.bio.net> NNTP-Posting-Host: net.bio.net Unsere Tochter, 4 Jahre, hat ca. 2- 3 mal pro Jahr anhaltend hohes Fieber <42 oC Blutwerte: Leucozyten >20000 - CRP > 410 mg/l - Thrombocyten 697 Ausgeschlossen wurde: Meningitis, Leukämie, Kissing Desease, Angina, Rheuma. Herz, Nieren, Magen, Blase, Mandeln unauffällig, Therapie bisher: Fiebermittel, Antibiotika. Nach ca. 3-4 Tagen Besserung. Haben Sie einen Diagnose/Therapie - Vorschlag . Vielen Dank! rpk.koch@t-online.de